CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system. [electronic resource]
Producer: 20130312Description: 463-72 p. digitalISSN:- 1526-7598
- Adrenergic Uptake Inhibitors -- pharmacology
- Adrenergic alpha-1 Receptor Antagonists -- pharmacology
- Adrenergic alpha-2 Receptor Antagonists -- pharmacology
- Adrenergic beta-Antagonists -- pharmacology
- Amides
- Analgesics -- pharmacology
- Animals
- Arachidonic Acids -- antagonists & inhibitors
- Cannabinoid Receptor Agonists -- pharmacology
- Dinoprostone
- Endocannabinoids -- antagonists & inhibitors
- Ethanolamines -- antagonists & inhibitors
- Male
- Morpholines -- pharmacology
- Norepinephrine -- physiology
- Pain Measurement -- drug effects
- Palmitic Acids -- antagonists & inhibitors
- Peripheral Nerves -- drug effects
- Polyunsaturated Alkamides -- antagonists & inhibitors
- Prazosin -- pharmacology
- Propranolol -- pharmacology
- Rats
- Rats, Wistar
- Reboxetine
- Receptor, Cannabinoid, CB1 -- agonists
- Receptor, Cannabinoid, CB2 -- agonists
- Sympathetic Nervous System -- drug effects
- Yohimbine -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.